

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 7.90253229 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 6.86932261 |
| 3 | viral transcription (GO:0019083) | 6.50613563 |
| 4 | translational termination (GO:0006415) | 6.20500986 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 6.02094812 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.02094812 |
| 7 | protein neddylation (GO:0045116) | 5.90320648 |
| 8 | GDP-mannose metabolic process (GO:0019673) | 5.66002192 |
| 9 | translational elongation (GO:0006414) | 5.46636211 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.22279618 |
| 11 | protein targeting to ER (GO:0045047) | 5.15689834 |
| 12 | cotranslational protein targeting to membrane (GO:0006613) | 5.14538860 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 5.08573880 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.95541411 |
| 15 | protein localization to endoplasmic reticulum (GO:0070972) | 4.89950940 |
| 16 | viral life cycle (GO:0019058) | 4.82898872 |
| 17 | cellular protein complex disassembly (GO:0043624) | 4.70954938 |
| 18 | nucleoside transmembrane transport (GO:1901642) | 4.66937096 |
| 19 | mannose metabolic process (GO:0006013) | 4.47513401 |
| 20 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.31511021 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.18607304 |
| 22 | translational initiation (GO:0006413) | 3.92623886 |
| 23 | nucleoside transport (GO:0015858) | 3.87204610 |
| 24 | thrombin receptor signaling pathway (GO:0070493) | 3.83990930 |
| 25 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.82766123 |
| 26 | ribosomal large subunit biogenesis (GO:0042273) | 3.76504293 |
| 27 | protein complex disassembly (GO:0043241) | 3.73584884 |
| 28 | DNA deamination (GO:0045006) | 3.72869916 |
| 29 | protein targeting to membrane (GO:0006612) | 3.66493538 |
| 30 | negative regulation of heart rate (GO:0010459) | 3.59985420 |
| 31 | interferon-gamma production (GO:0032609) | 3.58220313 |
| 32 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.49595217 |
| 33 | maturation of SSU-rRNA (GO:0030490) | 3.46344033 |
| 34 | macromolecular complex disassembly (GO:0032984) | 3.45001388 |
| 35 | ATP biosynthetic process (GO:0006754) | 3.44258327 |
| 36 | translation (GO:0006412) | 3.35969414 |
| 37 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.34115037 |
| 38 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.32373969 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.31241182 |
| 40 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.29787817 |
| 41 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.27396652 |
| 42 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.27396652 |
| 43 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.26693410 |
| 44 | regulation of immunoglobulin secretion (GO:0051023) | 3.26190856 |
| 45 | reproduction (GO:0000003) | 3.21244860 |
| 46 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.21170771 |
| 47 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.18923207 |
| 48 | NADH dehydrogenase complex assembly (GO:0010257) | 3.18923207 |
| 49 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.18923207 |
| 50 | respiratory electron transport chain (GO:0022904) | 3.17057623 |
| 51 | electron transport chain (GO:0022900) | 3.16940610 |
| 52 | regulation of mitochondrial membrane potential (GO:0051881) | 3.16866121 |
| 53 | protein complex biogenesis (GO:0070271) | 3.16255217 |
| 54 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09804103 |
| 55 | cellular component biogenesis (GO:0044085) | 3.05609737 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.04101853 |
| 57 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.03724366 |
| 58 | modified amino acid transport (GO:0072337) | 3.02653558 |
| 59 | protein prenylation (GO:0018342) | 3.02231818 |
| 60 | prenylation (GO:0097354) | 3.02231818 |
| 61 | GTP biosynthetic process (GO:0006183) | 3.01994622 |
| 62 | antibacterial humoral response (GO:0019731) | 3.00933810 |
| 63 | peroxisome fission (GO:0016559) | 2.99490968 |
| 64 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.99088875 |
| 65 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.97613211 |
| 66 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.95954909 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 2.95082604 |
| 68 | cardiolipin metabolic process (GO:0032048) | 2.91577493 |
| 69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.81896118 |
| 70 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.80070211 |
| 71 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.79957593 |
| 72 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.77938245 |
| 73 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.77080965 |
| 74 | negative regulation of response to food (GO:0032096) | 2.75670706 |
| 75 | negative regulation of appetite (GO:0032099) | 2.75670706 |
| 76 | innate immune response in mucosa (GO:0002227) | 2.75382060 |
| 77 | positive regulation of isotype switching (GO:0045830) | 2.73914139 |
| 78 | mRNA catabolic process (GO:0006402) | 2.71818519 |
| 79 | regulation of podosome assembly (GO:0071801) | 2.71796400 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 2.71730395 |
| 81 | amine catabolic process (GO:0009310) | 2.71730395 |
| 82 | antimicrobial humoral response (GO:0019730) | 2.71561616 |
| 83 | neuronal action potential propagation (GO:0019227) | 2.69733437 |
| 84 | behavioral response to nicotine (GO:0035095) | 2.69432503 |
| 85 | positive regulation of DNA recombination (GO:0045911) | 2.68764389 |
| 86 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.68131900 |
| 87 | cytidine deamination (GO:0009972) | 2.67138294 |
| 88 | cytidine metabolic process (GO:0046087) | 2.67138294 |
| 89 | cytidine catabolic process (GO:0006216) | 2.67138294 |
| 90 | positive regulation of fatty acid transport (GO:2000193) | 2.66925680 |
| 91 | positive regulation of icosanoid secretion (GO:0032305) | 2.65334033 |
| 92 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.63721908 |
| 93 | signal peptide processing (GO:0006465) | 2.63238897 |
| 94 | establishment of protein localization to membrane (GO:0090150) | 2.62859459 |
| 95 | UTP biosynthetic process (GO:0006228) | 2.55570123 |
| 96 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.54484621 |
| 97 | positive regulation of respiratory burst (GO:0060267) | 2.53326996 |
| 98 | positive regulation of activated T cell proliferation (GO:0042104) | 2.53298963 |
| 99 | positive regulation of mast cell activation (GO:0033005) | 2.52503353 |
| 100 | platelet dense granule organization (GO:0060155) | 2.51722409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.38309660 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.35442371 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.73244287 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.63872230 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.22450651 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.94364777 |
| 7 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61312612 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.56109883 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.52333440 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.33868726 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.29923507 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27619829 |
| 13 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.03005238 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.94001489 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.67372757 |
| 16 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.63471256 |
| 17 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.54890560 |
| 18 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.53435567 |
| 19 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.49881449 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49422412 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47330742 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41182035 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40636912 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40313371 |
| 25 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.37765816 |
| 26 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.35123125 |
| 27 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33295468 |
| 28 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31703892 |
| 29 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29017002 |
| 30 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24690548 |
| 31 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.23366989 |
| 32 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.23244531 |
| 33 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.20296889 |
| 34 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.20193681 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20145925 |
| 36 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19815408 |
| 37 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19815408 |
| 38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.19336114 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18862922 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18403203 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17640681 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15342394 |
| 43 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14683867 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13789996 |
| 45 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.13342798 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13339759 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13122381 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12923997 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12628453 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12559525 |
| 51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12429107 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11293231 |
| 53 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10096758 |
| 54 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.10037090 |
| 55 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09239651 |
| 56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07732992 |
| 57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07586065 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07586065 |
| 59 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.07103723 |
| 60 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06413698 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05311626 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04622362 |
| 63 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04609874 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04152217 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99852642 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99830908 |
| 67 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.99185778 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98770333 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98103411 |
| 70 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.97615148 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97601829 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97599182 |
| 73 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97512560 |
| 74 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97273620 |
| 75 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.95807694 |
| 76 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.95519139 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95447479 |
| 78 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95176643 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95175372 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94373529 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93992478 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93147716 |
| 83 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92950542 |
| 84 | NFYB_21822215_ChIP-Seq_K562_Human | 0.91742987 |
| 85 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.91681696 |
| 86 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91657260 |
| 87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.91229475 |
| 88 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90051189 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89149320 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89021426 |
| 91 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.88625759 |
| 92 | ERA_21632823_ChIP-Seq_H3396_Human | 0.88515073 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88190596 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87935716 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87595091 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87046185 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86452345 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86245116 |
| 99 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.85709816 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 0.82966959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 7.34645465 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.23455129 |
| 3 | MP0002638_abnormal_pupillary_reflex | 3.60029253 |
| 4 | MP0005671_abnormal_response_to | 3.25764034 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.93270563 |
| 6 | MP0003646_muscle_fatigue | 2.81912323 |
| 7 | MP0008872_abnormal_physiological_respon | 2.38948126 |
| 8 | MP0003724_increased_susceptibility_to | 2.02654191 |
| 9 | MP0001873_stomach_inflammation | 2.00819931 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 1.95466870 |
| 11 | MP0010155_abnormal_intestine_physiology | 1.93567422 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 1.91043673 |
| 13 | MP0005387_immune_system_phenotype | 1.90652761 |
| 14 | MP0001790_abnormal_immune_system | 1.90652761 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90294506 |
| 16 | MP0006292_abnormal_olfactory_placode | 1.89823309 |
| 17 | MP0008004_abnormal_stomach_pH | 1.83107794 |
| 18 | MP0001663_abnormal_digestive_system | 1.78971460 |
| 19 | MP0004147_increased_porphyrin_level | 1.74669068 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.74140512 |
| 21 | MP0004142_abnormal_muscle_tone | 1.66877262 |
| 22 | MP0001545_abnormal_hematopoietic_system | 1.63993769 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.63993769 |
| 24 | MP0001188_hyperpigmentation | 1.63689100 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.57838894 |
| 26 | MP0000343_altered_response_to | 1.55569220 |
| 27 | MP0005360_urolithiasis | 1.51388167 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.50674220 |
| 29 | MP0004885_abnormal_endolymph | 1.49017552 |
| 30 | MP0002736_abnormal_nociception_after | 1.46047725 |
| 31 | MP0000230_abnormal_systemic_arterial | 1.45406720 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.43667653 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.42464229 |
| 34 | MP0001800_abnormal_humoral_immune | 1.39610663 |
| 35 | MP0004043_abnormal_pH_regulation | 1.38569741 |
| 36 | MP0003186_abnormal_redox_activity | 1.38387768 |
| 37 | MP0005670_abnormal_white_adipose | 1.36783735 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.35522448 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.33545593 |
| 40 | MP0000685_abnormal_immune_system | 1.31214519 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.25926466 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.22791553 |
| 43 | MP0009785_altered_susceptibility_to | 1.21423504 |
| 44 | MP0004858_abnormal_nervous_system | 1.20991811 |
| 45 | MP0005389_reproductive_system_phenotype | 1.18430162 |
| 46 | MP0005381_digestive/alimentary_phenotyp | 1.17332915 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.15801946 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.15451904 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.15322654 |
| 50 | MP0003879_abnormal_hair_cell | 1.13179350 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.12721915 |
| 52 | MP0009764_decreased_sensitivity_to | 1.12596003 |
| 53 | MP0001905_abnormal_dopamine_level | 1.12075244 |
| 54 | MP0001664_abnormal_digestion | 1.11711056 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 1.09333270 |
| 56 | MP0002160_abnormal_reproductive_system | 1.07701464 |
| 57 | MP0002723_abnormal_immune_serum | 1.06441671 |
| 58 | MP0003303_peritoneal_inflammation | 1.04562781 |
| 59 | MP0002095_abnormal_skin_pigmentation | 1.02872475 |
| 60 | MP0005410_abnormal_fertilization | 1.01327057 |
| 61 | MP0002234_abnormal_pharynx_morphology | 0.99649816 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 0.99465527 |
| 63 | MP0002398_abnormal_bone_marrow | 0.98048953 |
| 64 | MP0000678_abnormal_parathyroid_gland | 0.97795950 |
| 65 | MP0001919_abnormal_reproductive_system | 0.95799690 |
| 66 | MP0006276_abnormal_autonomic_nervous | 0.95364808 |
| 67 | MP0003718_maternal_effect | 0.94445949 |
| 68 | MP0001765_abnormal_ion_homeostasis | 0.94040140 |
| 69 | MP0003436_decreased_susceptibility_to | 0.92548174 |
| 70 | MP0001529_abnormal_vocalization | 0.91826717 |
| 71 | MP0005025_abnormal_response_to | 0.91554215 |
| 72 | MP0002452_abnormal_antigen_presenting | 0.91146164 |
| 73 | MP0000490_abnormal_crypts_of | 0.88690290 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.88565768 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.88243658 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.87817088 |
| 77 | MP0001727_abnormal_embryo_implantation | 0.87612920 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.86846553 |
| 79 | MP0002420_abnormal_adaptive_immunity | 0.85698635 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.85417350 |
| 81 | MP0000372_irregular_coat_pigmentation | 0.83869601 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.83428514 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 0.82386271 |
| 84 | MP0001819_abnormal_immune_cell | 0.81637261 |
| 85 | MP0004215_abnormal_myocardial_fiber | 0.80382903 |
| 86 | MP0002733_abnormal_thermal_nociception | 0.79088008 |
| 87 | MP0002429_abnormal_blood_cell | 0.78397114 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.78110597 |
| 89 | MP0010329_abnormal_lipoprotein_level | 0.77958649 |
| 90 | MP0003011_delayed_dark_adaptation | 0.75038488 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.73772583 |
| 92 | MP0004130_abnormal_muscle_cell | 0.73065305 |
| 93 | MP0000716_abnormal_immune_system | 0.72786484 |
| 94 | MP0001970_abnormal_pain_threshold | 0.72544021 |
| 95 | MP0003866_abnormal_defecation | 0.70875700 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 0.70864640 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.70094822 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.68958129 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.68789646 |
| 100 | MP0004019_abnormal_vitamin_homeostasis | 0.68064046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acanthocytosis (HP:0001927) | 6.65907166 |
| 2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.70066032 |
| 3 | Decreased central vision (HP:0007663) | 4.44510127 |
| 4 | Global brain atrophy (HP:0002283) | 4.04157033 |
| 5 | Prolonged bleeding time (HP:0003010) | 3.99981610 |
| 6 | Petechiae (HP:0000967) | 3.82139674 |
| 7 | Poikilocytosis (HP:0004447) | 3.70068560 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 3.51595000 |
| 9 | Purpura (HP:0000979) | 3.51155578 |
| 10 | Menorrhagia (HP:0000132) | 3.46598421 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 3.42846204 |
| 12 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.41907392 |
| 13 | Stomatitis (HP:0010280) | 3.36994697 |
| 14 | Exertional dyspnea (HP:0002875) | 3.36831127 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.35519608 |
| 16 | Dyskinesia (HP:0100660) | 3.31057560 |
| 17 | Acute necrotizing encephalopathy (HP:0006965) | 3.29078540 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.18988537 |
| 19 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.13388224 |
| 20 | Increased CSF lactate (HP:0002490) | 3.10209091 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.05835681 |
| 22 | Increased mean platelet volume (HP:0011877) | 3.03752534 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94809935 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.92955856 |
| 25 | Pallor (HP:0000980) | 2.92216638 |
| 26 | Increased intramyocellular lipid droplets (HP:0012240) | 2.91737643 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.91371693 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 2.87708540 |
| 29 | Macrocytic anemia (HP:0001972) | 2.86588687 |
| 30 | Acute encephalopathy (HP:0006846) | 2.86000810 |
| 31 | Abnormal platelet volume (HP:0011876) | 2.76702387 |
| 32 | Progressive macrocephaly (HP:0004481) | 2.73027411 |
| 33 | Glycosuria (HP:0003076) | 2.67120618 |
| 34 | Abnormality of urine glucose concentration (HP:0011016) | 2.67120618 |
| 35 | Epistaxis (HP:0000421) | 2.64064075 |
| 36 | Methylmalonic acidemia (HP:0002912) | 2.63272444 |
| 37 | Hyperglycinemia (HP:0002154) | 2.62311024 |
| 38 | Reticulocytopenia (HP:0001896) | 2.60467573 |
| 39 | Decreased muscle mass (HP:0003199) | 2.57679816 |
| 40 | Pendular nystagmus (HP:0012043) | 2.57669189 |
| 41 | Hepatocellular necrosis (HP:0001404) | 2.56217942 |
| 42 | Abnormality of alanine metabolism (HP:0010916) | 2.49070128 |
| 43 | Hyperalaninemia (HP:0003348) | 2.49070128 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49070128 |
| 45 | Abnormal hemoglobin (HP:0011902) | 2.48947652 |
| 46 | Hepatic necrosis (HP:0002605) | 2.48528716 |
| 47 | Patent foramen ovale (HP:0001655) | 2.46894892 |
| 48 | Paralysis (HP:0003470) | 2.45358625 |
| 49 | Increased muscle lipid content (HP:0009058) | 2.43899631 |
| 50 | Neurodegeneration (HP:0002180) | 2.43432697 |
| 51 | Congenital stationary night blindness (HP:0007642) | 2.43154867 |
| 52 | Hyperlipoproteinemia (HP:0010980) | 2.42895994 |
| 53 | Agitation (HP:0000713) | 2.40376275 |
| 54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.39504383 |
| 55 | Congenital sensorineural hearing impairment (HP:0008527) | 2.34901864 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.34272337 |
| 57 | Attenuation of retinal blood vessels (HP:0007843) | 2.33657050 |
| 58 | Acute hepatic failure (HP:0006554) | 2.26704243 |
| 59 | Nausea (HP:0002018) | 2.25941958 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.25151974 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.23760601 |
| 62 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.18235975 |
| 63 | Respiratory difficulties (HP:0002880) | 2.17579777 |
| 64 | Increased IgM level (HP:0003496) | 2.16371205 |
| 65 | Akinesia (HP:0002304) | 2.14804886 |
| 66 | Microretrognathia (HP:0000308) | 2.11412855 |
| 67 | Renal tubular dysfunction (HP:0000124) | 2.08919646 |
| 68 | Optic disc pallor (HP:0000543) | 2.08247576 |
| 69 | Dyschromatopsia (HP:0007641) | 2.07279375 |
| 70 | Abnormality of vitamin B metabolism (HP:0004340) | 2.06326996 |
| 71 | Abnormality of the basal ganglia (HP:0002134) | 2.06176685 |
| 72 | Abnormal ciliary motility (HP:0012262) | 2.05842376 |
| 73 | Abnormality of renal resorption (HP:0011038) | 2.04432818 |
| 74 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.02498424 |
| 75 | Stenosis of the external auditory canal (HP:0000402) | 2.00443840 |
| 76 | CNS demyelination (HP:0007305) | 1.97305985 |
| 77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.96774352 |
| 78 | Dysphonia (HP:0001618) | 1.95062389 |
| 79 | Methylmalonic aciduria (HP:0012120) | 1.94501444 |
| 80 | Brushfield spots (HP:0001088) | 1.93777045 |
| 81 | Type 2 muscle fiber atrophy (HP:0003554) | 1.92641720 |
| 82 | Constricted visual fields (HP:0001133) | 1.91623049 |
| 83 | Abnormality of magnesium homeostasis (HP:0004921) | 1.89339699 |
| 84 | Abnormality of the 2nd finger (HP:0004100) | 1.88934784 |
| 85 | IgG deficiency (HP:0004315) | 1.86181527 |
| 86 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85004959 |
| 87 | Clumsiness (HP:0002312) | 1.84834134 |
| 88 | Generalized aminoaciduria (HP:0002909) | 1.84142306 |
| 89 | Short femoral neck (HP:0100864) | 1.83382644 |
| 90 | Muscle fiber atrophy (HP:0100295) | 1.80475084 |
| 91 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80440027 |
| 92 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.79158538 |
| 93 | Gingival bleeding (HP:0000225) | 1.78845846 |
| 94 | Cerebral edema (HP:0002181) | 1.78685517 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.77692742 |
| 96 | Abnormal urine phosphate concentration (HP:0012599) | 1.76601599 |
| 97 | Metabolic alkalosis (HP:0200114) | 1.76495518 |
| 98 | Increased serum lactate (HP:0002151) | 1.76420175 |
| 99 | Abnormal number of erythroid precursors (HP:0012131) | 1.76251377 |
| 100 | Hypoproteinemia (HP:0003075) | 1.75680305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.20029636 |
| 2 | NME2 | 3.41441625 |
| 3 | MYLK | 2.64918942 |
| 4 | TXK | 2.55055136 |
| 5 | ADRBK2 | 2.34830217 |
| 6 | TEC | 2.24902158 |
| 7 | MAP4K2 | 2.21073401 |
| 8 | GRK1 | 2.17400374 |
| 9 | BMPR2 | 2.16737735 |
| 10 | CDK19 | 2.15292425 |
| 11 | RIPK4 | 2.13153091 |
| 12 | MAP2K6 | 2.01173711 |
| 13 | MAP4K1 | 1.81250752 |
| 14 | ILK | 1.81168822 |
| 15 | TAOK3 | 1.79109014 |
| 16 | MAP3K12 | 1.78914728 |
| 17 | PDK2 | 1.77168661 |
| 18 | WNK4 | 1.65059189 |
| 19 | GRK6 | 1.61663896 |
| 20 | BTK | 1.61385169 |
| 21 | TIE1 | 1.55805374 |
| 22 | ACVR1B | 1.53520223 |
| 23 | AKT3 | 1.49388157 |
| 24 | TLK1 | 1.48852075 |
| 25 | ERN1 | 1.41571185 |
| 26 | BMX | 1.38034485 |
| 27 | SYK | 1.37409323 |
| 28 | NUAK1 | 1.35448585 |
| 29 | CSF1R | 1.33385711 |
| 30 | PIK3CG | 1.32195297 |
| 31 | OXSR1 | 1.19476174 |
| 32 | IKBKB | 1.15770101 |
| 33 | DYRK2 | 1.13438876 |
| 34 | ADRBK1 | 1.10412308 |
| 35 | BMPR1B | 1.10388569 |
| 36 | KIT | 1.05056747 |
| 37 | DAPK3 | 1.04339040 |
| 38 | ITK | 1.03918639 |
| 39 | EIF2AK1 | 1.01733835 |
| 40 | PASK | 1.01651622 |
| 41 | TNIK | 1.01106989 |
| 42 | TGFBR1 | 1.00102677 |
| 43 | TRPM7 | 0.99582688 |
| 44 | LRRK2 | 0.98610245 |
| 45 | LCK | 0.95368249 |
| 46 | PINK1 | 0.95237027 |
| 47 | PTK2B | 0.93815466 |
| 48 | MATK | 0.93664390 |
| 49 | STK3 | 0.93385735 |
| 50 | INSRR | 0.92987119 |
| 51 | DAPK2 | 0.86551016 |
| 52 | GRK5 | 0.85168916 |
| 53 | STK39 | 0.84573141 |
| 54 | PRKCG | 0.83137550 |
| 55 | FES | 0.82221147 |
| 56 | PRKG2 | 0.81670635 |
| 57 | WNK3 | 0.79897403 |
| 58 | PKN1 | 0.78727871 |
| 59 | TNK2 | 0.74921181 |
| 60 | EPHB2 | 0.74901570 |
| 61 | AKT2 | 0.72753193 |
| 62 | ABL2 | 0.72750730 |
| 63 | OBSCN | 0.70029155 |
| 64 | ZAP70 | 0.69887362 |
| 65 | TRIM28 | 0.68792062 |
| 66 | PIM1 | 0.68361549 |
| 67 | PRKACA | 0.68234155 |
| 68 | RPS6KA6 | 0.67541869 |
| 69 | MAP3K11 | 0.65958348 |
| 70 | BRAF | 0.65845317 |
| 71 | LYN | 0.65679634 |
| 72 | FLT3 | 0.64735482 |
| 73 | FRK | 0.64509214 |
| 74 | PRKACG | 0.64111089 |
| 75 | PRKCQ | 0.62394633 |
| 76 | PRKCA | 0.61668985 |
| 77 | PRKCD | 0.59102708 |
| 78 | PAK1 | 0.57183296 |
| 79 | PNCK | 0.56851571 |
| 80 | HCK | 0.56060118 |
| 81 | RPS6KL1 | 0.55839000 |
| 82 | RPS6KC1 | 0.55839000 |
| 83 | CSK | 0.53946109 |
| 84 | CSNK2A1 | 0.53624057 |
| 85 | PIM2 | 0.53002453 |
| 86 | ZAK | 0.52940293 |
| 87 | CSNK2A2 | 0.52801849 |
| 88 | STK4 | 0.52128335 |
| 89 | PRKCH | 0.50860237 |
| 90 | SGK2 | 0.50835540 |
| 91 | CAMK2A | 0.48832473 |
| 92 | AURKA | 0.48457805 |
| 93 | PDK1 | 0.48431645 |
| 94 | BCKDK | 0.46986316 |
| 95 | PRKG1 | 0.46398377 |
| 96 | MKNK1 | 0.45959109 |
| 97 | MINK1 | 0.44157527 |
| 98 | SGK494 | 0.43349972 |
| 99 | SGK223 | 0.43349972 |
| 100 | PLK4 | 0.42548974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.50252257 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.63907265 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.28501175 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.26844426 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.88147931 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.81300226 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.74954381 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66090863 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52446199 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.44281929 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.38789236 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17922589 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16921299 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.80142650 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.78663658 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76636053 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75122119 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.73574859 |
| 19 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.65319477 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60033227 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55220478 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.52230540 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51241265 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44608580 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44433633 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42700818 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.26157987 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.25184102 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24276492 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18876207 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17730905 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.16657992 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16536152 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13003272 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07101651 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96905647 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94746487 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 0.94114340 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93097949 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91100092 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 0.90057104 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89179052 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87338778 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86204370 |
| 45 | Protein export_Homo sapiens_hsa03060 | 0.84883533 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83759028 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80964915 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78813504 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77073990 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75932115 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75828177 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75714620 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75474386 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74655105 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70903544 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67995285 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67712792 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67576840 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65892050 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.64823584 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62366615 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61542491 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60550901 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.59120930 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58877459 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57828626 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56312597 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56067047 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55430832 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54662474 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53697817 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51907343 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.50606843 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49816502 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48685842 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.47866791 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46296102 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46179593 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44735542 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44529508 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43913740 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38526420 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37994331 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36951580 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36244856 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35456332 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35065442 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34261711 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34251289 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29986986 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29004608 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27937319 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26877886 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26664906 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26087014 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25930055 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.25662926 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.21504372 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.20819486 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.16027230 |

